Angela Yee-MoonWang Hong Kong/SingaporeSingapore

Angela Yee-MoonWang
She is Clinical Professor of Duke-National University of Singapore Academic Medical Center, and Senior Consultant at Singapore General Hospital. She is the current Chair of ISN Education Working Group, ISN Councilor, and Chair of ISN North & East Asia Regional Board. She is also immediate Past President of International Society of Renal Nutrition and Metabolism (ISRNM), Council member of ISPD, Previous Exe Committee member of KDIGO. She is also a Committee Member of ISN-ACT, Exe Committee Member of SONG. She has served as a workgroup member of international clinical practice guidelines (CPG) including ISPD Prescribing High Quality Goal-Directed PD Guidelines 2020, ISPD-GREX Practice Recommendations on Physical Activity and Exercise in PD 2021 and KDOQI Nutrition Guidelines 2020 and KDIGO anemia guidelines in CKD 2022. She serves on the editorial board of ASN Journals, Kidney Int, NDT (theme Editor), Nephron Clinical Practice. She has received ISPD John Maher Award 2006 and NKF Joel D. Kopple Award 2018 and Thomas Addis Award, a lifetime award of the ISRNM in Dec 2022. She has published >240 papers, 15 book chapters, delivered >150 invited lectures in international meetings. She is recognized for her research in cardiovascular, metabolic and nutrition complications in CKD. She also works in clinical trials and innovations to improve outcomes of kidney patients.
Institution

Day 1 - Sunday April 14, 2024

Time Session
3 p.m.
4 p.m.
Angela Yee-MoonWang Chairperson angela.wang@duke-nus.edu.sgHong Kong/SingaporeSingapore
ThiagoDe Azevedo Reis Chairperson thiagoreisnefro@gmail.comHospital Sírio-Libanês, São Paulo, Brazil & Fenix Brazil
  • Is Magnesium a Missing Puzzle for Vascular Calcification in CKD?
    SolaAoun Bahous Speaker sola.bahous@gmail.comLebanese American University School of MedicineLebanon
  • Should Potassium Be Restricted or Not in CKD?
    RobertoPecoits Filho Speaker roberto.pecoits@arborresearch.orgArbor Research Collaborative for HealthUnited States
  • Metabolic Acidosis in CKD: When to Treat? What to Target?
    MitchellRosner Speaker MHR9R@hscmail.mcc.virginia.eduUniveristy of Virginia HealthUnited States
  • Q and A
Hall A

Day 2 - Monday April 15, 2024

Time Session
3 p.m.
4 p.m.
MitchellRosner Chairperson MHR9R@hscmail.mcc.virginia.eduUniveristy of Virginia HealthUnited States
  • Overview of Hyponatremia
    Angela Yee-MoonWang Speaker angela.wang@duke-nus.edu.sgHong Kong/SingaporeSingapore
  • Pro: Current Guidelines are Appropriate
    HelbertRondon-Berrios Speaker rondonberriosh@upmc.eduUniversity of Pittsburgh School of MedicineUnited States
  • Con: Current Guidelines are Too Conservative
    CarlosAyus Speaker carlosayus@yahoo.comUniversity of California IrvineUnited States
  • Discussion
Hall C3

Day 3 - Tuesday April 16, 2024

Time Session
12:30 p.m.
1:30 p.m.
Angela Yee-MoonWang Chairperson angela.wang@duke-nus.edu.sgHong Kong/SingaporeSingapore
ArmandoNegri Chairperson armando.negri@gmail.comInstituto de Investigaciones Metabólicas, Universidad del Salvador, Buenos Aires, ArgentinaArgentina
  • CKD-induced Changes in Gut Microbiome in CKD
    DeniseMafra Speaker dmafra30@gmail.comFederal University Fluminense - UFFBrazil
  • Personalized Nutrition Management of CKD Patients
    ConnieRhee Speaker crhee@mednet.ucla.eduUCLAUnited States
  • The Gut-Kidney-Heart Axis in CKD: Beyond the Leaky Gut
    KeiichiSumida Speaker ksumida@uthsc.eduUniversity of Tennessee Health Science CenterUnited States
  • Q and A
Hall C4